1. Home
  2. ALXO vs JOB Comparison

ALXO vs JOB Comparison

Compare ALXO & JOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALXO
  • JOB
  • Stock Information
  • Founded
  • ALXO 2015
  • JOB 1893
  • Country
  • ALXO United States
  • JOB United States
  • Employees
  • ALXO N/A
  • JOB N/A
  • Industry
  • ALXO Biotechnology: Pharmaceutical Preparations
  • JOB Diversified Commercial Services
  • Sector
  • ALXO Health Care
  • JOB Consumer Discretionary
  • Exchange
  • ALXO Nasdaq
  • JOB Nasdaq
  • Market Cap
  • ALXO 24.0M
  • JOB 21.8M
  • IPO Year
  • ALXO 2020
  • JOB N/A
  • Fundamental
  • Price
  • ALXO $1.17
  • JOB $0.20
  • Analyst Decision
  • ALXO Strong Buy
  • JOB
  • Analyst Count
  • ALXO 6
  • JOB 0
  • Target Price
  • ALXO $3.30
  • JOB N/A
  • AVG Volume (30 Days)
  • ALXO 1.7M
  • JOB 156.5K
  • Earning Date
  • ALXO 08-12-2025
  • JOB 08-13-2025
  • Dividend Yield
  • ALXO N/A
  • JOB N/A
  • EPS Growth
  • ALXO N/A
  • JOB N/A
  • EPS
  • ALXO N/A
  • JOB N/A
  • Revenue
  • ALXO N/A
  • JOB $108,752,000.00
  • Revenue This Year
  • ALXO N/A
  • JOB $43.94
  • Revenue Next Year
  • ALXO N/A
  • JOB N/A
  • P/E Ratio
  • ALXO N/A
  • JOB N/A
  • Revenue Growth
  • ALXO N/A
  • JOB N/A
  • 52 Week Low
  • ALXO $0.40
  • JOB $0.17
  • 52 Week High
  • ALXO $2.59
  • JOB $0.51
  • Technical
  • Relative Strength Index (RSI)
  • ALXO 75.79
  • JOB 38.56
  • Support Level
  • ALXO $0.80
  • JOB $0.19
  • Resistance Level
  • ALXO $1.04
  • JOB $0.21
  • Average True Range (ATR)
  • ALXO 0.11
  • JOB 0.01
  • MACD
  • ALXO 0.05
  • JOB -0.00
  • Stochastic Oscillator
  • ALXO 96.85
  • JOB 34.00

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

About JOB GEE Group Inc.

GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.

Share on Social Networks: